Absology

Absology is a biotech company in Anyang, South Korea, founded in 2017. It has raised $53.5M across 3 rounds, most recently a $14.5M Venture Round in 2025 (est.).

Global Standard for In-Vitro Diagnostic Devices

Headquarters
Anyang
Employees
11–50
Founded
2017
Business Model
B2B
Total Funding
$53.5M
Last Round
$14.5M Venture RoundJan 2025
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds for this company. The full record is or through the API.

About

Absology is a South Korean biomedical company founded in March 2017 that develops and manufactures in-vitro immunodiagnostic medical devices for point-of-care testing (POCT). Its core 'ABSOL' platform uses fluorescence immunoassay (FIA) and microfluidic technology to deliver rapid quantitative diagnosis of cancer markers, cardiac conditions, hormones, and sepsis — matching the accuracy of large lab equipment in a compact device. The company sells its diagnostic platforms and reagent kits to hospitals, clinics, and distributors in approximately 30 countries, and also offers veterinary diagnostics through its 'Absol VET' product line.

Summary

It lists 11–50 employees. It has raised $53.5M in total across 3 rounds, most recently a $14.5M Venture Round in 2025 (est.).

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Venture RoundVenture Round2025 (est.)
$14.5M

Sign up to see all 3 events

Funding: Series C through Venture Round. Amounts, valuations, and investors where available.

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Absology on Indexed.vc
<a href="https://indexed.vc/companies/absology"><img src="https://indexed.vc/api/badge/company/absology" alt="Absology on Indexed.vc" width="260" height="76" /></a>